Your money | Banking, Finance and Investing

Complaint claims seven executive asked amber harrison do you really want to be that girl

THE former mistress of Seven boss Tim Worner says she was told she would be branded Australia’s Monica Lewinsky if she exposed their affair.

Former executive assistant Amber Harrison claims that a senior female executive said Monica Lewinsky has never recovered from her dalliance with Bill Clinton, according to the Herald Sun.

Do you really want to be that girl and have this all come out in public? the exec allegedly said.

You are just some girl who slept with a guy at work. This isnt worth more than what we are offering you.

You let a guy use you for sex for two years. That is what everyone is going to say about you if this gets out, the exec said, according to the claim.

Ms Harrison alleges the executive also mentioned the 2010 David Jones sexual harassment case and the fact the girl involved had not worked since.

All four women named by Ms Harrison as also having affairs with Mr Worner, have strongly denied the allegations and threatened legal action if their identities are made public.

Ms Harrison suggested four other women had sexual relationships with Mr Worner, including two network TV stars, but Addisons law firm sent letters to publishers on behalf of the women denying this.

On Monday, the board of Seven West Media grilled Mr Worner about the allegations of other affairs and also asked him about claims he did drugs at work.

According to the Herald Sun, Mr Worner denied he had ever done drugs in a work context or that he had any other relationships with people in the company.

Seven West Media has been under pressure to replace the chief executive officer next year over his affair with the junior colleague, who later received a confidential settlement after leaving the company.

The Australian Shareholders Association has called on Seven Wests board to start planning for Mr Worners exit from the top job next year, saying the controversy around his 2012 affair with Ms Harrison could not be put to rest while he retains his position.

ASA director Stephen Mayne said the reputational damage to Seven West would not be fully resolved until the company had a new CEO and said the succession plan is something they should progress in 2017.

We are not saying that Tim Worner should be marched out of the building but we are saying that Seven needs to activate its succession management plans in 2017, Mr Mayne said.

Its hard to see how an issue like this can be fully put behind Seven in the medium term with the CEO in place.

A statement from Seven West late on Monday revealed the broadcaster made a confidential settlement with Ms Harrison, a former executive assistant to the companys magazines boss, more than two years ago, with payments made to her as part of the terms.

Mr Worner said he is filled with the deepest shame and regret over the two-year affair, which was widely reported in media on Monday after Ms Harrison went public with complaints about her treatment by the company.

Seven West has stood by Mr Worner, saying in the statement that chairman Kerry Stokes had made it clear the conduct was completely unacceptable but affirming he will stay on as CEO.

Seven West shares rose 6 per cent to 79.5 cents on Tuesday, recovering most of a price plunge suffered on Monday in the wake of the affair revelations.

Nurofen feels pain over medicine claim

DRUG-MAKER Reckitt Benckiser is facing millions of dollars in fines after a court found it misled consumers over claims Nurofen could target different kinds of pain.

The Australian Competition and Consumer Commission took the company to the Federal Court in March this year alleging it had made false and misleading claims in marketing its Nurofen Specific Pain range, on the packaging and on its website.

Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain, and Nurofen Tension Headache, which were nearly double the price of Nurofens standard ibuprofen products, were marketed as treating specific kinds of pain, when in fact the products are identical.

Reckitt Benckiser admitted it had contravened the law. The court has ordered the products be removed from retail shelves within three months. Interim packaging will clearly disclose to consumers that the products are equally effective for other forms of pain.

The court has also ordered that Reckitt Benckiser publish website and newspaper corrective notices, implement a consumer protection compliance program, and pay the ACCCs costs.

The ACCC took these proceedings because it was concerned that consumers may have purchased these products in the belief that they specifically treated a certain type of pain, based on the representations on the packaging, when this was not the case, ACCC Chairman Rod Sims said in a statement.

Truth in advertising and consumer issues in the health and medical sectors are priority areas for the ACCC, to ensure that consumers are given accurate information when making their purchasing decisions. Any representations which are difficult for a consumer to test will face greater scrutiny from the ACCC.

A hearing on penalty will be held at a future date. The company could be facing fines of up to $1.1 million per offence, and Mr Sims earlier told the ACCC would be seeking the maximum possible penalty.

It could amount to quite a severe penalty, he said in March. Where we have large companies like Coles, Woolworths and Reckitt Benckiser, we judge that these penalties need to be sizeable and need to be seen to be sizeable so you have the deterrence effect.

This whole truth in advertising drive requires a few big penalties, to be blunt, so that company directors sit up and take notice so they focus on what their marketing people are doing. Marketing people have a lot of temptations to cross the line, and they need to understand its not good for business or their balance sheet.

In a statement, Nurofen spokeswoman Montse Pena said the company did not set out to mislead consumers.

Nurofen has co-operated with the ACCC in relation to these proceedings and will fully comply with the court order made today, she said. The Nurofen specific-pain range was launched with an intention to help consumers navigate their pain relief options, particularly within the grocery environment where there is no healthcare professional to assist decision making.

The packaging around our food protects the food and makes it look good, but sometimes it misleads us, and some plastic packaging contains potentially harmful chemicals that can pass into our food.